vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and Teradyne (TER). Click either name above to swap in a different company.
Teradyne is the larger business by last-quarter revenue ($1.1B vs $617.8M, roughly 1.8× Hims & Hers Health, Inc.). Teradyne runs the higher net margin — 23.7% vs 3.3%, a 20.4% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (43.9% vs 28.4%). Teradyne produced more free cash flow last quarter ($218.8M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 34.4%).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.
HIMS vs TER — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $617.8M | $1.1B |
| Net Profit | $20.6M | $257.2M |
| Gross Margin | 71.9% | 57.2% |
| Operating Margin | 1.5% | 27.1% |
| Net Margin | 3.3% | 23.7% |
| Revenue YoY | 28.4% | 43.9% |
| Net Profit YoY | -20.8% | 75.9% |
| EPS (diluted) | $0.08 | $1.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $617.8M | $1.1B | ||
| Q3 25 | $599.0M | $769.2M | ||
| Q2 25 | $544.8M | $651.8M | ||
| Q1 25 | $586.0M | $685.7M | ||
| Q4 24 | $481.1M | $752.9M | ||
| Q3 24 | $401.6M | $737.3M | ||
| Q2 24 | $315.6M | $729.9M | ||
| Q1 24 | $278.2M | $599.8M |
| Q4 25 | $20.6M | $257.2M | ||
| Q3 25 | $15.8M | $119.6M | ||
| Q2 25 | $42.5M | $78.4M | ||
| Q1 25 | $49.5M | $98.9M | ||
| Q4 24 | $26.0M | $146.3M | ||
| Q3 24 | $75.6M | $145.6M | ||
| Q2 24 | $13.3M | $186.3M | ||
| Q1 24 | $11.1M | $64.2M |
| Q4 25 | 71.9% | 57.2% | ||
| Q3 25 | 73.8% | 58.4% | ||
| Q2 25 | 76.4% | 57.2% | ||
| Q1 25 | 73.5% | 60.6% | ||
| Q4 24 | 76.8% | 59.4% | ||
| Q3 24 | 79.2% | 59.2% | ||
| Q2 24 | 81.3% | 58.3% | ||
| Q1 24 | 82.4% | 56.6% |
| Q4 25 | 1.5% | 27.1% | ||
| Q3 25 | 2.0% | 18.9% | ||
| Q2 25 | 4.9% | 13.9% | ||
| Q1 25 | 9.9% | 17.6% | ||
| Q4 24 | 3.9% | 20.4% | ||
| Q3 24 | 5.6% | 20.6% | ||
| Q2 24 | 3.5% | 28.8% | ||
| Q1 24 | 3.6% | 13.0% |
| Q4 25 | 3.3% | 23.7% | ||
| Q3 25 | 2.6% | 15.5% | ||
| Q2 25 | 7.8% | 12.0% | ||
| Q1 25 | 8.4% | 14.4% | ||
| Q4 24 | 5.4% | 19.4% | ||
| Q3 24 | 18.8% | 19.8% | ||
| Q2 24 | 4.2% | 25.5% | ||
| Q1 24 | 4.0% | 10.7% |
| Q4 25 | $0.08 | $1.62 | ||
| Q3 25 | $0.06 | $0.75 | ||
| Q2 25 | $0.17 | $0.49 | ||
| Q1 25 | $0.20 | $0.61 | ||
| Q4 24 | $0.10 | $0.89 | ||
| Q3 24 | $0.32 | $0.89 | ||
| Q2 24 | $0.06 | $1.14 | ||
| Q1 24 | $0.05 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.6M | $293.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $540.9M | $2.8B |
| Total Assets | $2.2B | $4.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $228.6M | $293.8M | ||
| Q3 25 | $345.8M | $272.7M | ||
| Q2 25 | $1.1B | $339.3M | ||
| Q1 25 | $273.7M | $475.6M | ||
| Q4 24 | $220.6M | $553.4M | ||
| Q3 24 | $165.5M | $510.0M | ||
| Q2 24 | $129.3M | $421.9M | ||
| Q1 24 | $105.2M | $707.4M |
| Q4 25 | $540.9M | $2.8B | ||
| Q3 25 | $581.0M | $2.7B | ||
| Q2 25 | $562.7M | $2.8B | ||
| Q1 25 | $549.3M | $2.8B | ||
| Q4 24 | $476.7M | $2.8B | ||
| Q3 24 | $440.1M | $2.9B | ||
| Q2 24 | $362.0M | $2.7B | ||
| Q1 24 | $344.5M | $2.6B |
| Q4 25 | $2.2B | $4.2B | ||
| Q3 25 | $2.2B | $4.0B | ||
| Q2 25 | $1.9B | $3.8B | ||
| Q1 25 | $891.7M | $3.7B | ||
| Q4 24 | $707.5M | $3.7B | ||
| Q3 24 | $602.3M | $3.8B | ||
| Q2 24 | $480.5M | $3.6B | ||
| Q1 24 | $448.1M | $3.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.3M | $281.6M |
| Free Cash FlowOCF − Capex | $-2.5M | $218.8M |
| FCF MarginFCF / Revenue | -0.4% | 20.2% |
| Capex IntensityCapex / Revenue | 10.3% | 5.8% |
| Cash ConversionOCF / Net Profit | 2.98× | 1.09× |
| TTM Free Cash FlowTrailing 4 quarters | $57.4M | $450.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $61.3M | $281.6M | ||
| Q3 25 | $148.7M | $49.0M | ||
| Q2 25 | $-19.1M | $182.1M | ||
| Q1 25 | $109.1M | $161.6M | ||
| Q4 24 | $86.4M | $282.6M | ||
| Q3 24 | $85.3M | $166.3M | ||
| Q2 24 | $53.6M | $216.1M | ||
| Q1 24 | $25.8M | $7.3M |
| Q4 25 | $-2.5M | $218.8M | ||
| Q3 25 | $79.3M | $2.4M | ||
| Q2 25 | $-69.5M | $131.7M | ||
| Q1 25 | $50.1M | $97.6M | ||
| Q4 24 | $59.5M | $225.2M | ||
| Q3 24 | $79.4M | $114.4M | ||
| Q2 24 | $47.6M | $171.2M | ||
| Q1 24 | $11.8M | $-36.7M |
| Q4 25 | -0.4% | 20.2% | ||
| Q3 25 | 13.2% | 0.3% | ||
| Q2 25 | -12.8% | 20.2% | ||
| Q1 25 | 8.5% | 14.2% | ||
| Q4 24 | 12.4% | 29.9% | ||
| Q3 24 | 19.8% | 15.5% | ||
| Q2 24 | 15.1% | 23.5% | ||
| Q1 24 | 4.3% | -6.1% |
| Q4 25 | 10.3% | 5.8% | ||
| Q3 25 | 11.6% | 6.1% | ||
| Q2 25 | 9.3% | 7.7% | ||
| Q1 25 | 10.1% | 9.3% | ||
| Q4 24 | 5.6% | 7.6% | ||
| Q3 24 | 1.5% | 7.0% | ||
| Q2 24 | 1.9% | 6.1% | ||
| Q1 24 | 5.0% | 7.3% |
| Q4 25 | 2.98× | 1.09× | ||
| Q3 25 | 9.43× | 0.41× | ||
| Q2 25 | -0.45× | 2.32× | ||
| Q1 25 | 2.20× | 1.63× | ||
| Q4 24 | 3.32× | 1.93× | ||
| Q3 24 | 1.13× | 1.14× | ||
| Q2 24 | 4.03× | 1.16× | ||
| Q1 24 | 2.32× | 0.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HIMS
Segment breakdown not available.
TER
| Soc | $646.5M | 60% |
| Memory | $206.5M | 19% |
| Transferred At Point In Time | $90.0M | 8% |
| Universal Robots | $89.4M | 8% |
| IST | $30.5M | 3% |
| Transferred Over Time | $20.5M | 2% |
